Amazon Ads Rejected for Medical Claims: What the Claims Policy Actually Requires

Your Sponsored Products campaign stops, and the rejection notice says the creative makes medical claims. The product is a magnesium blend, a collagen powder, a red-light device, or a protein bar with a "supports immunity" line. Nothing about it feels medical to you, and that is usually where the review goes wrong on the seller side. Amazon Ads does not decide this with a banned-word list. It decides with three separate gates, and only one of them is really about wording.

The short version: Amazon reviews claims for accuracy and substantiation, prohibits a short list of claims outright, and separately restricts where certain healthcare categories may run. A rewrite can fix the first two. It cannot open a closed placement, and it cannot manufacture a study you do not have.

The rejection notice names a symptom, not the rule

Amazon Ads says it uses "a combination of automation and expert human review" to monitor ads, and that rejection emails include the reason plus guidance on what to change. Since February 2026 it no longer emails you when an ad is approved or moves into review, so the console is the place to check status. Amazon puts typical status checks at "usually within 24 hours, but this could take up to 3 business days," and review can run longer during high submission volume.

"Medical claims" is therefore a review label attached to a decision, not a single policy clause. Before you touch the copy, work out which of the three gates the reviewer actually applied. Amazon's own policy pages draw the lines: Claims and substantiation, Healthcare products and services, and General requirements.

Gate 1: Is the claim accurate, and can you prove it?

The general requirements tell advertisers to "ensure the accuracy of claims and provide factual substantiation if requested by Amazon." That "if requested" matters. You are not only answering a rejection; you can be asked for the file later, after the ad has been running and spending.

For healthcare products, the claims policy is more specific. It separates three claim types and says where the evidence may sit. The packaging exemption is the detail most sellers miss: if the claim is printed on the product packaging, Amazon does not ask for further substantiation in the ad.

The policy note attached to that section says the substantiation requirement covers healthcare products "excluding personal care products," and also reaches over-the-counter products "when making certain claims." Read that twice before assuming a skincare ad inherits the supplement rules, or the other way around.

Gate 2: The claims that are prohibited outright

These are not substantiation problems. No evidence file fixes them, because the policy forbids the claim itself. In the claims policy, the list is:

• Weight-management ads suggesting the product alone, without diet, exercise, or a calorie-controlled diet, can achieve results, or that a weight-loss product is effective for everyone.
• Weight-management ads guaranteeing permanent weight loss, a specific rate of weight loss, or that weight will not be regained after stopping the product.
• Content that encourages unhealthy eating habits or negative body image, and any use of before-and-after imagery.
• Claims that a non-prescription product is as effective as a prescription product.
• Regulatory endorsement claims on healthcare products.
• Books claiming to cure a high-risk disease or ailment.

This is where the popular advice to "just soften the wording" falls apart. "Prescription-strength formula" is not cured by swapping in "professional strength," because the problem is the comparison, not the adjective. In the same policy, before-and-after imagery is a format restriction tied to the weight-management rules: the photographs can be real, documented, and your own, and the ad still cannot use them.

Gate 3: Category and placement, which no rewrite can open

The healthcare policy groups consumer healthcare products by sensitivity and attaches placement limits. Two groups matter for most US supplement and beauty advertisers:

• Category 2, which includes Weight Loss. Ads are prohibited on Fire TV, Fire tablet, Alexa, and the Amazon store homepage; homepage placement on Twitch and IMDb is prohibited; and audience creation tied to purchases or views of those products is prohibited, as is the use of Advertiser Audiences built from advertiser data.
• Category 3, which includes fat burners, metabolism boosters, appetite suppressants, GLP-1 supplements, and skin tag and wart removers. Amazon store placement must be contextual, Prime Video Display must exclude certain content ratings, and the same audience-creation prohibitions apply.

Prescription pharmaceuticals sit further out again: reviewed case by case and permitted in the United States, New Zealand, and Canada only, with restricted audience targeting. Separately, the healthcare policy prohibits clinical trial recruitment, experimental medical treatments, and medical devices marketed for professional use.

Here is the practical consequence. If your weight-loss creative is accurate, substantiated, and free of prohibited claims, it can still be ineligible for the placement you bought. Rewriting the headline will not change that. The general requirements also tell advertisers to "accurately declare their category upon campaign set-up," so a misdeclared category is its own compliance problem rather than a shortcut around these limits.

Why the same copy passed on your listing page

Listing compliance and ad compliance are different reviews with different scopes. An ad includes the creative, the destination, and the category declaration, and Amazon says ads, assets, destinations, and other content that violate policy can be blocked. A listing that survived catalog review, or a supplement that cleared the documentation test covered in our Amazon supplement listing guide, is not automatically an eligible ad.

That distinction is why a rejection can feel arbitrary. The listing reviewer asked whether the product could be sold. The ad reviewer asked whether this specific claim, in this specific format, may be shown to this audience in this placement.

Where the FDA line sits, and why a disclaimer is not a fix

US law and Amazon policy run in parallel. Under the FDA framework, structure/function claims describe the role of a nutrient or ingredient in affecting normal structure or function, are not pre-approved, require substantiation that the claim is truthful and not misleading, require a notification to FDA within 30 days of marketing, and require the disclaimer that the statement has not been evaluated by FDA and the product is not intended to diagnose, treat, cure, or prevent any disease. Only a drug can lawfully make that last kind of claim.

The DSHEA disclaimer does not neutralize an ad claim for Amazon's purposes. A supplement ad saying it "reverses insulin resistance" is a disease claim under the FDA framework and, separately, an accuracy and substantiation problem under Amazon's claims policy. Bolting the disclaimer onto the creative does not convert the sentence into a compliant one.

FDA's current page on structure/function claims and the disclaimer text in 21 CFR 101.93 are the primary sources to read before you decide a line is "just marketing."

A review method that survives a second look

1. Freeze the rejected unit. Note which asset failed: headline, video, image, landing page, or the campaign category itself. The console status and the rejection email usually point at one of them.
2. Build a claim inventory. Pull every assertion from the copy, the voiceover, on-screen text, the image, the packaging, and the landing page. Sellers routinely fix the headline and leave the same claim in the video captions.
3. Classify each claim into a gate. Prohibited, substantiation-required, or category/placement. A claim can land in more than one.
4. Check the location and the date. If the claim is not on packaging, the source and date must appear on the creative, packaging, or landing page. Endorsements and comparisons need evidence dated within 24 months; environmental claims need a date within 24 months.
5. Check eligibility separately. Confirm the product's sensitivity tier and whether the placement you bought permits it at all.
6. Rewrite only what the evidence supports. Every rewrite should be defensible from the same evidence file, not from a nicer adjective.
7. Resubmit once, with a change log. If the ad is compliant and the rejection looks wrong, use the appeal link in Amazon's decision message. Repeated violations can suspend the account, and the suspension length tracks severity.

Five hypothetical rewrites, labeled as hypothetical

These are illustrative examples written for this article. None of them has been reviewed or approved by Amazon, and none is a template to copy without your own evidence.

What a checker can and cannot do

A claim checker is useful for the first pass: it can flag absolute claims, implied prescription comparisons, and weight-loss phrasing, and it can suggest hedged alternatives in English. It shortens the inventory step, which is the step sellers skip.

It cannot approve an ad, cannot replace a study or a supplier certificate, cannot resolve a category placement restriction, and cannot guarantee reinstatement. Those sit with Amazon's review process and, where law is involved, with your regulatory counsel. If you want to run a first pass on English copy, our supplement claim checker and ad compliance checker are built for exactly that scope. For the broader workflow, see ByeRisk for ads.

Before you resubmit

• The claim inventory covers copy, voiceover, captions, images, packaging, and landing page.
• Every prohibited claim is removed, not reworded.
• Every substantiation-required claim has a source and a date on an allowed surface.
• Endorsement and comparison evidence is dated within 24 months, and environmental claims carry a date within 24 months.
• The product's sensitivity tier and the purchased placement both allow the ad.
• The campaign category declared at setup matches the product.
• The resubmission includes a short change log, so the next reviewer can see what moved.

FAQ

Does Amazon Ads ban the word "medical"?

No. The policies target claims and their support, not a vocabulary list. "Medical" in a rejection notice is a reviewer's shorthand for a claim that was treated as a health or medical assertion, which is why editing individual words rarely resolves it.

Can I say a supplement "supports immune health"?

That phrasing describes a structure or function, so it is not automatically prohibited. It still has to be accurate and not misleading, and on a healthcare product the effectiveness substantiation rule can apply unless the claim is on the packaging. Do not read this as approval; read it as the test you have to pass.

Why was the ad rejected when the same text is on my product page?

Because the reviews are different. Ad review covers the creative, the destination, and the campaign category, and Amazon can block ads, assets, and destinations that violate policy. A compliant listing does not make the ad compliant.

Does adding the FDA disclaimer fix a rejected claim?

No. The disclaimer is a labeling requirement for structure/function claims. It does not make a disease claim permissible, and it does not satisfy Amazon's accuracy and substantiation requirements.

How do I appeal, and how long does review take?

Use the appeal link in the message that communicated the decision. Ad status is usually visible within 24 hours and can take up to 3 business days, longer during high submission volume. Resubmitting the same creative without a change is not an appeal strategy.

Policy sources reviewed 2026-10-31: Amazon Ads Advertising policies, Claims and substantiation, Healthcare products and services, Ads content moderation, General requirements, and the ad policy change log; FDA Structure/Function Claims (content current as of 2024-03-28); 21 CFR 101.93. Platform policy is not legal advice.